Formulation design and characterization of an elementary osmotic pump tablet of flurbiprofen

PDA Journal of Pharmaceutical Science and Technology

Volumn 68, Issue 4, 2014, Pages 333-346

  Patel, Kunal N ^a   Mehta, Tejal A ^a  

^a NIRMA UNIVERSITY   (India)

Author keywords

Cellulose acetate; Delivery orifice; Elementary osmotic pump; Zero order drug release; cyclodextrin

Indexed keywords

CELLULOSE ACETATE; FLURBIPROFEN; MACROGOL; OSMOTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT;

ARTICLE; CUMULATIVE DRUG RELEASE; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; ELEMENTARY OSMOTIC PUMP; INFRARED SPECTROSCOPY; OSMOTIC PUMP; PH; TABLET; TABLET FRIABILITY; TABLET HARDNESS; TABLET THICKNESS; CHEMISTRY; MEDICINAL CHEMISTRY; OSMOSIS; SOLUBILITY;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHEMISTRY, PHARMACEUTICAL; DRUG DELIVERY SYSTEMS; DRUG LIBERATION; FLURBIPROFEN; OSMOSIS; SOLUBILITY; TABLETS;

EID: 84906225208     PISSN: 10797440     EISSN: 19482124     Source Type: Journal    
DOI: 10.5731/pdajpst.2014.00984     Document Type: Article

References (22)

1. Verma, R. K.; Garg, S. Current status of drug delivery technologies and future directions. Pharmaceut. Technol. On-Line 2001, 25 (2), 1-14.
2. Verma, R. K.; Divi, M. K.; Garg, S. Formulation aspects in the development of osmotically controlled oral drug delivery systems. J. Controlled Release 2002, 79 (1), 7-27. (Pubitemid 34164158)
3. Conley, R.; Gupta, S. K.; Sathyan, G. Clinical spectrum of the osmotic-controlled release oral delivery system (OROS), an advanced oral delivery form. Curr. Med. Res. Opin. 2006, 22 (10), 1879-1892. (Pubitemid 44663390)
4. Wong, P. S. L.; Gupta, S. K.; Stewart, B. E. Osmotically Controlled Tablets. In Modified-Release Drug Delivery Technology, Rathbone, M. J., Handgraft, J., Roberts, M. S., Eds.; Marcel Dekker, Inc.: New York, pp 101-114.
5. Santus, G.; Baker, R. W. Osmotic drug delivery: a review of the patent literature. J. Controlled Release 1995, 35 (1), 1-21.
6. Theeuwes, F. Elementary osmotic pump. J. Pharm. Sci. 1975, 64 (12), 1987-1991.
7. Swanson, D. R.; Barclay, B. L.; Wong, P. S. L.; Theuwes, F. Nifedipine gastrointestinal therapeutic system. Am. J. Med. 1987, 83 (6), 3-9.
8. Wong, P. S. L.; Barclay, B. L.; Deters, J. C.; Theeuwes, F. Osmotic Device for Administering Certain Drugs. U.S. Patent 4,765,989, 1986.
9. Grundy, J. S.; Foster, R. T. The nifedipine gastrointestinal therapeutic system (GITS). Evaluation of pharmaceutical, pharmacokinetic and pharmacological properties Clin. Pharmacokinet. 1996, 30 (1), 28-51. (Pubitemid 26030419)
10. Geerke, J. H. Method and Apparatus for Forming Dispenser Delivery Ports. U.S. Patent 5,658,474, 1997.
11. Herbig, S. M.; Cardinal, J. R.; Korsmeyer, R. W.; Smith, K. L. Asymmetric membrane tablet coating for osmotic drug delivery. J. Controlled Release 1995, 35 (2), 127-136.
12. Chiou, W. L.; Riegelman, S. Pharmaceutical application of solid dispersion systems. J. Pharm. Sci. 1971, 60 (9), 1281-1302.
13. Okimoto, K.; Rajewski, R. A.; Stella, V. J. Release of testosterone from an osmotic pump tablets utilizing (SBE) 7m-β-CD as both a solubilizing and an osmotic pump agent. J. Controlled Release 1999, 58 (1), 29-38. (Pubitemid 29371811)
14. Marsh, C. C.; Schuna, A. A.; Sundstorm, W. R. A review of selected investigational nonsteroidal antiinflammatory drugs of the 1980s. Pharmacotherapy 1986, 6 (1), 10-25.
15. Thaller, V. T.; Kulshrestha, M. K.; Bell, K. The effect of pre-operative topical flurbiprofen or diclofenac on pupil dilatation. Eye 2000, 14 (4), 642-645.
16. Kanagale, P.; Patel, V.; Venkatesan, N.; Jain, M.; Patel, P.; Misra, A. Pharmaceutical development of solid dispersion based osmotic drug delivery system of nifedipine. Curr. Drug Deliv. 2008, 5 (4), 306-311.
17. Mehramizi, A.; Asgari, M. E.; Pourfarzib, M.; Bayati, K. H.; Dorkoosh, F. A.; Rafiee-Tehrani, M. Influence of β-cyclodextrin complexation on lovastatin release from osmotic pump tablets. DARU J. Pharm. Sci. 2007, 15 (2), 71-78. (Pubitemid 47075881)
18. Mehramizi, A.; Alijani, B.; Pourfarzib, M.; Dorkoosh, F. A.; Tehrani, M. R. Solid carriers for improved solubility of glipizide in osmotically controlled oral drug delivery system. Drug Dev. Ind. Pharm. 2007, 33 (8), 812-823. (Pubitemid 47345852)
19. Shah, T. J.; Amin, A. F.; Parikh, J. R.; Parikh, R. H. Process optimization and characterization of poloxamer solid dispersions of a poorly water-soluble drug. AAPS PharmSciTech 2007, 8 (2), E1-E7.
20. Lu, E. X.; Jiang, Z. Q.; Zhang, Q. Z.; Jiang, X. G. A water-insoluble drug monolithic osmotic tablet system utilizing gum Arabic as an osmotic, suspending and expanding agent. J. Controlled Release 2003, 92 (3), 375-382.
21. Chauhan, C. S.; Choudhury, P. K. Controlled porosity osmotic pump for the delivery of flurbiprofen. Curr. Drug Deliv. 2006, 3 (2), 193-198. (Pubitemid 43725016)
22. Philip, A. K. Osmotically regulated flow of flurbiprofen through in situ formed asymmetric membrane capsule. Curr. Drug Deliv. 2008, 5 (2), 127-132. (Pubitemid 351536319)